Cargando…
Disease management of patients with immune thrombocytopenia—results of a representative retrospective survey in Germany
Clinical research has resulted in an improvement of treatment options for patients with immune thrombocytopenia (ITP) over the last years. However, only few data exist on the real-life management of patients with ITP. To expand the knowledge, a multicenter, national survey was undertaken in 26 hemat...
Autores principales: | Kubasch, Anne Sophie, Kisro, Jens, Heßling, Jörg, Schulz, Holger, Hurtz, Hans-Jürgen, Klausmann, Martine, Ehrnsperger, Achim, Willy, Claudia, Platzbecker, Uwe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419449/ https://www.ncbi.nlm.nih.gov/pubmed/32710167 http://dx.doi.org/10.1007/s00277-020-04173-5 |
Ejemplares similares
-
Successful Use of Eltrombopag in a Young Child With Chronic Immune Thrombocytopenia
por: Gruhn, Bernd, et al.
Publicado: (2021) -
Beyond the Edge of Hypomethylating Agents: Novel Combination Strategies for Older Adults with Advanced MDS and AML
por: Kubasch, Anne Sophie, et al.
Publicado: (2018) -
Setting Fire to ESA and EMA Resistance: New Targeted Treatment Options in Lower Risk Myelodysplastic Syndromes
por: Kubasch, Anne Sophie, et al.
Publicado: (2019) -
Facing the challenge: Novel treatment options for patients with myelodysplastic syndromes
por: Kubasch, Anne Sophie, et al.
Publicado: (2018) -
Case Report: Personalized Therapeutical Approaches with Lenalidomide in Del(5q): A Case Series
por: Stein, Anna, et al.
Publicado: (2022)